Your browser doesn't support javascript.
loading
Delivery of Bordetella pertussis adenylate cyclase toxin to target cells via outer membrane vesicles.
Donato, Gina M; Goldsmith, Cynthia S; Paddock, Christopher D; Eby, Joshua C; Gray, Mary C; Hewlett, Erik L.
Affiliation
  • Donato GM; Department of Medicine, Division of Infectious Diseases, University of Virginia School of Medicine, Charlottesville, VA 22908, USA. gmd2n@virginia.edu
FEBS Lett ; 586(4): 459-65, 2012 Feb 17.
Article in En | MEDLINE | ID: mdl-22289177
ABSTRACT
Bordetella pertussis adenylate cyclase toxin (ACT) intoxicates cells by producing intracellular cAMP. B. pertussis outer membrane vesicles (OMV) contain ACT on their surface (OMV-ACT), but the properties of OMV-ACT were previously unknown. We found that B. pertussis in the lung from a fatal pertussis case contains OMV, suggesting an involvement in pathogenesis. OMV-ACT and ACT intoxicate cells with and without the toxin's receptor CD11b/CD18. Intoxication by ACT is blocked by antitoxin and anti-CD11b antibodies, but not by cytochalasin-D; in contrast, OMV-ACT is unaffected by either antibody and blocked by cytochalasin-D. Thus OMV-ACT can deliver ACT by processes distinct from those of ACT alone.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Bordetella pertussis / Adenylate Cyclase Toxin Type of study: Etiology_studies Limits: Animals / Humans Language: En Year: 2012 Type: Article

Full text: 1 Database: MEDLINE Main subject: Bordetella pertussis / Adenylate Cyclase Toxin Type of study: Etiology_studies Limits: Animals / Humans Language: En Year: 2012 Type: Article